ArticleCurrent oncology (Toronto, Ont.)2022

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer.

Bin Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.